WEANING FROM MECHANICAL VENTILATION - PowerPoint PPT Presentation

1 / 55
About This Presentation
Title:

WEANING FROM MECHANICAL VENTILATION

Description:

WEANING FROM MECHANICAL VENTILATION Dr MEGHA JAIN University College of Medical Sciences & GTB Hospital, Delhi ventilation without artificial airway Nasal , face mask ... – PowerPoint PPT presentation

Number of Views:1230
Avg rating:3.0/5.0
Slides: 56
Provided by: anaesthes
Category:

less

Transcript and Presenter's Notes

Title: WEANING FROM MECHANICAL VENTILATION


1
WEANING FROM MECHANICAL VENTILATION
  • Dr MEGHA JAIN

University College of Medical Sciences GTB
Hospital, Delhi
2
HEADINGS
  • Purpose of weaning and extubation.
  • Rationale of predictive indices in weaning.
  • Application of weaning parameters.
  • Methods of weaning.
  • Impediments to weaning.
  • Extubation and terminal weaning.

3
Different stages in mech. Ventilated pts.
1. Treatment of ARF
3. Assessing readiness to wean
5. Extubation
6. Reintubation
2. Suspicion
4. SBT
Admit
Discharge
4
DEFINITIONS
  • Weaning is the gradual reduction in the level of
    ventilatory support.
  • Weaning success effective spontaneous breathing
    without any mechanical assisstance for 24 hrs or
    more.
  • Weaning failure when pt is returned to
    mechanical ventilation after any length of
    weaning trial.
  • Signs of weaning failure abnormal blood gases,
    diaphoresis, tachycardia, tachypnea, arrythmias,
    hypotension.

5
Morbidity Associated With Prolonged Intubation
and Mechanical Ventilation
  • Vocal cord granulomas
  • Ulceration of the true vocal cords
  • Circumferential fibrous stenosis of trachea
  • Epithelial damage, loss of cilia, and impairment
    of tracheal mucus clearance
  • Risk factor for nosocomial pneumonia
  • Precludes oral feeding

6
The assessment of weaning proceeds in two phases
  • Phase 1 To ensure that certain basic criteria
  • regarding initial reason for
  • mechanical ventilation are satisfied
  • Phase 2 Determine whether weaning is likely
  • to succeed on the basis of specified
  • criteria

7
READINESS FOR VENTILATOR WEANING
  • Major determinants of ability to wean can be
    classified into three categories
  • oxygenation
  • ventilatory pump function
  • neuropsychiatric status

8
OXGYGENATION
  • Criteria of Adequacy
  • PaO2 gt 60 mmHg on FIO2 lt0.4 at minimal PEEP,
  • PaO2/FIO2gt200
  • Selected causes of failure
  • Hypoventilation neurologic injury or drugs
  • V/Q mismatch severe CHF
  • Anatomic (R-to-L) shunt (e.g. intracardiac,
    pulmonary
  • A-V malformation).

9
VENTILATION
  • Criterion of Adequacy
  • PaCO2 lt 50 mmHg or within 8 mmHg of baseline
  • Selected causes of failure
  • respiratory drive sedation, drug overdose.
  • resp bellows function diaph weakness, N-m
    disease
  • CO2 production without compensatory ? in alveolar
    Ve
  • fever, hypermetabolism, carbohydrate overfeeding
  • - dead space ventilation without compensatory ?
    alveolar Ve
  • PE, bullous emphysema

10
NEUROPSYCHIATRIC INTEGRITY
  • Criteria of adequacy
  • Awake, alert, cooperative, with intact gag
    and swallowing
  • Selected causes of failure
  • Cerebrovascular accident
  • Sleep deprivation/ICU psychosis
  • Drug therapy
  • Depression
  • Psychological dependency on ventilatory
    support

11
WEANING CRITERIA
  • Used to evaluate the readiness of a patient for
    weaning trial.
  • Common weaning criteria Ventilatory
    criteria Oxygenation criteria Pulmonary
    reserve Pulmonary measurements Other
    factors

12
VENTILATORY CRITERIA
  • PaCO2 lt 50 mmhg with pH gt/
    7.35.
  • VC gt 10 to 15 ml/kg
  • Spontaneous VT gt 5 to 8 ml/kg
  • Spontaneous RR lt 30/min
  • Minute ventilation lt 10 lts

PaCO2 most reliable indicator VC and spon VT
indicate mechanical cond of lungs A high spon RR
and MV indicate ? WOB
13
OXYGENATION CRITERIA
  • PaO2 without PEEP gt 60 mmhg _at_FiO2 upto 0.4
  • PaO2 with PEEP gt 100 mmhg _at_ FiO2 upto
    0.4
  • SaO2 gt 90 _at_ FiO2 upto
    0.4
  • Qs/Qt lt 20
  • P(A-a)O2 lt 350 mmhg
  • PaO2/FiO2 gt 200 mmhg

Qs/Qt estimate wasted pulmonary
perfusion P(A-a)O2 is related to degree of
hypoxemia/shunt In pts with anemia or dysfunct
Hb, PaO2 and SaO2 dont reflect true oxygenation
status So arterial oxygen content should be
measured
14
PULMONARY RESERVE AND MEASUREMENTS
  • Pulmonary reserve
  • Max. voluntary ventilation 2min.
    vent_at_FiO2 upto 0.4
  • Max. Insp. Pressure lt -20
    to -30 cmH2O in 20 sec.
  • Pulmonary measurements
  • Static compliance gt 30
    ml/cm H2O
  • Vd/Vt
    lt 60

Pulmonary reserve requires active pt
cooperation Pulmonary measurements indicate
workload needed to support spont. ventilation
15
COMBINED WEANING INDICES
  • Simplified weaning index evaluates efficiency of
    gas exchange. ( fmv (PIP PEEP)/MIP)
    PaCO2/40. should be lt 9/min.
  • CROP index evaluates pulmonary gas exchange and
    balance b/w respiratory demands and respiratory
    neuromuscular reserve. ( Cd MIP
    PaO2/PAO2)/f. Should be gt 13 ml/breath/min.
  • RSBI should be lt 105 cycles/min/lt.
    f/Vt. Most accurate test to predict
    weaning success.

16
RSBI
  • First described by Yang and Tobin in 1991.
  • Its a one min. trial of unassisted breathing
    measured during the T piece trial.
  • Main defect excessive false ves
  • Should not be measured until sedative and
    narcotic effects have adequately abated and the
    pt. triggers 2 to 3 breaths/min above ventilator
    set rate.
  • Measure RR and MV for 1 min. during unassisted
    breathing( 0 PEEP/5 cmH2O PSV).
  • At end of 1 min. divide MV by RR to calculate
    avg. tidal vol.
  • Divide RR by TV to obtain RSBI.

17
OTHER FACTORS
  • Metabolic factors Inadequate nutrition
    protein catabolism Overfeeding - ? CO2
    production Phosphate, ? Magnesium deficiency
    - ?respi pump functn Impaired O2 delivery -
    ?respi pump functn.
  • Renal function Patient should have adeq
    renal output (gt 1000 ml/day) Monitor
    electolytes to ensure adequate respi msl functn
  • Cardiovascular function Ensures sufficient
    O2 delivery to tissues Cardiac rate, rhythm,
    BP, CO and CI should be optimal with
    minimal pressure support
  • CNS assessment Assess for LOC, anxiety,
    dyspnea, motivation CNS should be intact for
    protection of airway.

18
Weaning methods
  • Spontaneous breathing trial
  • SIMV with pressure support.
  • PSV
  • Rapid ventilator discontinuation pt.on vent for
    lt 72 hrs., has good spont RR, MV, MIP, f/Vt
    SBT for 30 to 120
    min. EXTUBATE if no other limiting
    factor

19
Spontaneous Breathing Trial
  • T-Tube trial allows spont. breathing several
    times per day interspersed with periods of
    ventilatory support.
  • Initial SBTs may last only 5 to 30 min.
  • Resume mechanical ventilation at night or if
    distress occurs.

ADVANTAGES Tests pts spon breathing
ability Allows periods of work and rest Weans
faster than SIMV
DISADVANTAGES Abrupt transition difficult for sm
pts No alarms, unless attached to vent. Requires
careful observn.
20
Weaning protocol for a SBT with a T-Tube
Verify that pt is a candidate for vent.
discontinuation
Primary cause reversed
Pt is afebrile, awake, alert and free of seizures
HD stable with adeq. Hb, S.E.
Oxygenation and ventilation adequate PaO2gt/
60mmhg on FiO2 lt/ 0.4 with PEEP/CPAP lt/ 5 to 8
cmH2O PaO2/FiO2 gt 150 to 200 mmhg PaCO2 lt 50 pH
gt 7.35
Other indices - f/VT lt 105
- MIP lt -20 cm H2O -
f lt 30 and gt 6/min. - VC gt 10 to 15
ml/kg - TV gt 5 ml/kg

21
Weaning protocol for a SBT with a T-Tube
Prepare for T-Tube trial
Adequate staff, equipment, no sedatives
3 min. screening trial
Measure TV,RR Measure MIP thrice selecting the
best
Formal SBT of upto 2 hrs.
MIP lt -20 cm H20 TV spon. gt 5 ml/kg RR spon. lt
35/min.
Continue trial for 30 120 min.
Extubate if no signs of intolerance
22
Signs of intolerance of SBT
  • Agitation, anxiety, diaphoresis or change in
    mental status
  • RR gt 30 to 35/min
  • SpO2 lt 90
  • gt 20 ? or ? in HR or HR gt 120 to 140/min
  • SBP gt 180 or lt 90 mmhg.
  • Such pts are returned to full ventilatory
    support for 24 hrs. to allow the ventilatory
    msls. to recover.

23
Weaning with SIMV
  • Involves gradual reduction in machine rate based
    on ABG and clinical assessment.
  • Rate is generally adjusted in increments of 2
    breaths/min. followed by pt assessment.

ADVANTAGES Gradual transition Easy to use Minimum
MV guaranteed Alarm system may be used Should be
used in comb. with PSV/CPAP
DISADVANTAGES Pt. ventilator asynchrony Prolonge
s weaning May worsen fatigue
24
Pressure Support Ventilation (PSV)
Patient determines RR, VE, inspiratory time a
purely spontaneous mode
  • Parameters
  • Triggered by pts own breath
  • Limited by pressure
  • Affects inspiration only
  • Uses
  • Complement volume-cycled modes (i.e., SIMV)
  • Does not augment TV but overcomes resistance
    created by ventilator tubing
  • PSV alone
  • Used alone for recovering intubated pts who are
    not quite ready for extubation
  • Augments inflation volumes.

PSV is most often used together with other
volume-cycled modes. PSV provides sufficient
pressure to overcome the resistance of the
ventilator tubing, and acts during inspiration
only.
25
Pressure support ventilation
  • Begin with PSV that achieves a RR of 20 to 25/min
    or less.
  • Adjust pressure to achieve a TV of 8 to 10 ml/kg.
  • Reduce PSV 2 to 4 cm H2O as tolerated, ideally at
    least twice daily.
  • Consider extubation when pt. tolerates PSV of 5
    to 8 cm H2O for 2 hrs with no apparent distress.

26
Pressure support ventilation
ADVANTAGES Gradual transition Prevents
fatigue Increased pt comfort Weans faster than
SIMV alone Every breath is supported Pt can
control cycle length, rate and inspiratory
flow. Overcomes resistive WOB d/t ET tube and
circuit.
DISADVANTAGES Large changes in MV can occur ?ed
MAP versus T-Tube TV not guaranteed
27
Mandatory minute ventilation
  • Also called minimum minute ventilation, provides
    predetermined minute ventilation when pts spon.
    breathing effort becomes inadequate.
  • Prevents hypoventilation and respi. acidosis in
    final stages of weaning.
  • Trigger is ? in mandatory RR when actual MV lt
    preset MV.
  • All mandatory breaths are volume cycled.
  • Desired min. minute vol. is preset on the vent.
    Slightly lesser than that required to normalize
    PaCO2.
  • If distress pt tends to ? RR at expense of ? TV
    , leads to significant dead space ventilation

28
Mandatory minute ventilation
ADVANTAGES Backup ventilation ensured, Potential
to speed weaning compared with SIMV.
DISADVANTAGES May not ensure efficient pattern
of breathing, Rapid shallow breathing possible
with MMV.
29
Automatic Tube Compensation
  • Compensates for the resistance of ETT
  • Facilitates electronic weaning i.e pt during
    ATC mimic their breathing pattern as if extubated
    ( provided upper airway contorl provided)
  • OPERATION
  • As the flow ? / ETT dia ?, the P support needs to
    be ?to ?WOB

?P (P support) a (L / r4 ) a flow a WOB
30
  • Static condition single P support level can
    eliminate ETT resistance
  • Dynamic condition variable flow e.g. tachypnoea
    in diff phases of resp.
  • - P support needs
    to be continously altered
    to eliminate dynamically changing WOB d/t ETT
  • Feed resistive coef of ETT
  • Feed compensation desired
  • Measures
  • instantaneous flow

Calculates P support proportional to
resistance throughout respiratory cycle
Limitation resistive coef changes in vivo (
kinks, temp molding, secretions) Under/
overcompensation may result.
31
Proportional Assist Ventilation
  • Targets fixed portion of patients work during
    spontaneous breaths
  • Automatically adjusts flow, volume and pressure
    needed each breath

32
  • WOB
  • Ventilator measures elastance resistance
  • Clinician sets -Vol. assist reduces work of
    elastance
  • Flow assist reduces
    work of resistance's
  • Increased patient effort (WOB) causes increased
    applied pressure (and flow volume)

ELASTANCE (TV)
RESISTANCE (Flow)
33
  • Limitations
  • 1. Elastance (E) resistance (R) cannot be
    measured accurately.
  • 2. E R vary frequently esp in ICU patients.
  • 3. Curves to measure E ( PV curve) R(P-F curve
    ) are not linear as assumed by ventilator.

34
Noninvasive
  • ventilation without artificial airway
  • Nasal , face mask
  • adv.
  • Avoid intubation / c/c
  • Preserve natural airway defences
  • Comfort
  • Speech/ swallowing
  • Less sedation needed
  • Intermittent use
  • Disadv
  • Cooperation
  • Mask discomfort
  • Air leaks
  • Facial ulcers, eye irritation, dry nose
  • Aerophagia

35
Role of tracheostomy in weaning
  • Performed in ventilator dependent pts., timing is
    controversial.
  • Beneficial in ?ed sedation requirement,
    articulated speech, allowed orally, enhanced
    mobility.

36
Role of tracheostomy in weaning
  • Early tracheostomy ( in 2 days of admission )
    reduces mortality, risk of pneumonia, accidental
    extubation, ICU length of stay.

Reduces dead space Less airway resistance ?ed
WOB Better suctioning Improved pt comfort
Facilitates weaning
37
Complications
  • Misplacement
  • Hemorrhage
  • Obstruction
  • Displacement
  • Impairment of swallowing reflexes
  • Late tracheal stenosis.

38
Weaning failure
  • Defined as when pt is returned to mech.
    Ventilation after any length of weaning trial or
    is reintubated within 48 hrs following
    extubation.
  • Causes 1. ?ed air flow resistance- ET
    tube, abdominal distention, tracheal
    obstruction. 2. ?ed compliance-
    atelectasis, ARDS, tension pneumothorax,
    obesity, retained secretions, bronchospasm,
    kinking of ETtube. 3. Electrolyte imbalance,
    inadequate nutrition.

39
Indicators of weaning failure
  • Blood gases- ?ing PaCO2 ( gt50 mmhg) ?ing
    pH lt 7.30 ?ing PaO2 (lt60 mmhg)
    ?ing SpO2 (lt90) ?ing PaO2/FiO2
    (lt150 mmhg)
  • Vital signs- ?ing HR ( by gt 20/min. or gt
    110/min.) abnormal ECG changing BP ( 20
    mmhg SBP or 10 mmhg DBP)

40
Indicators of weaning failure
  • Respiratory parameters ?ing TV ( lt 250 ml)
    ?ing RR ( gt 30/min) ?ing f/TV
    ratio ( gt 105 cycles/L) ?ing MIP ( lt
    -20 cm H2O) ?ing static compliance ( lt 30
    ml/cm H2O) ?ing VD/VT ( gt 60)

41
Pathophysiology of weaning failure
  • NONRESPIRATORY PARAMETERS AFFECTING ABILITY TO
    WEAN

Nutritional status Fluid balance Metabolic and
acid-base derangements Cardiac Function Renal
function Neuropsychiatric factors
42
Nutritional status
  • Malnutrition has adverse effects on the
    respiratory system
  • ?respiratory muscle strength and function
  • ?diaphragmatic mass and contractility
  • ?endurance

43
Nutritional status
  • Overnutrition may impede weaning
  • High CO2
  • Produced by excessive CHO loading
  • Other causes of increased CO2 production fever,
    sepsis, shivering, seizures, and inefficient
    ventilation due to ? dead space, PE

44
Metabolic abnormalities
  • Hypophosphatemia
  • Hypocalcemia
  • Hypothyroidism

45
Sleep Deprivation and Psychological Issues
  • Twilight awareness -gt nap during the day -gt
    shift day-night cycle
  • Give sedative-hypnotic at bedtime to restore
    normal daily cycle
  • Depression in the long-term ICU patient
  • TCA at bedtime for sedative effect and to
    forestall depression.
  • Anxiety
  • Adequate sedation only to minimize detrimental
    WOB
  • Very slow changes in PS level to prevent
    anxiety induced by sudden changes to the response
    of the lung stretch receptors

46
Ventilator induced diaphragmatic dysfunction
  • VIDD loss of diaphragmatic force generating
    capacity related to use of mech. Ventilation
    can ocurr as early as 12 hrs. and reduction
    in max force production is of the order of 30
    50 after 1 3 days of CMV.
  • Causes of VIDD msl. atrophy, oxidative stress,
    structural injury, msl fiber remodelling.
  • Management - Minimise use of NM blockers,
    steroids Optimize PO4, Mg, nutrition.
    Cervical magnetic stimulation of phrenic
    nerve Antioxidant supplementation.

47
Critical care illness neuromyopathy
  • Causes sepsis, malnutrition, paralysing agents,
    sedatives, narcotics, steroids.
  • Affects all msls. Including diaphragm and
    intercostals.
  • B/L proximal msl weakness.
  • Diagnosis using Medical Research Council Score( lt
    48), electrophysiological testing and msl biopsy
    if appropriate.
  • Transdiaphragmatic pressure in response to B/L
    phrenic nerve stimulation.
  • Treatment options Good nutrition
    Withdrawal of offending drugs
    Inspiratory msl exercises

48
Prolonged mechanical ventilation
  • Required in 3 to 7 of ventilated pts.
  • Unless cause is irreversible ( high spinal cord
    injury) pt should not be considered permanently
    ventilator dependent until 3 mths of weaning
    attempts have failed.
  • Often transferred to regional weaning
    centers/long term care facilities.
  • Goal is to restore pt to highest level of
    independent function possible.

49
Complications of PMV
  • Infection
  • Bacterial Pneumonia
  • Line sepsis
  • Volume Overload
  • Laryngeal Edema
  • Pneumothorax
  • Tracheal Bleeding
  • Ileus
  • DVT
  • Additional Complications if Tracheostomy is
    necessary

50
Extubation
  • Discontinuation of invasive PPV involves 2 steps
    separation of pt. from vent. based on
    assessment of removal of artificial airway.
    airway patency protection

Parameters for airway patency Cuff leak
test Qualitative Quantitative audible
air leaklt 110 ml air leak

Parameters for airway protection Effective
cough Secretion volume Mental status
51
Extubation failure
  • Defined as need for reinstitution of vent.
    Support within 24 72 hrs. of ETT removal.
  • Occurs in 2 25 of pts.
  • Predisposing factors advanced age
    duration of mech. Vent. anemia use
    of cont. IV sedation semirecumbent
    positioning after extubation.
  • Find manage the cause.

52
Terminal weaning
  • Defined as withdrawal of mechanical ventilation
    that results in death of the pt.
  • 3 concerns must be evaluated and discussed
    pts informed consent medical futility
    reduction of pain and suffering
  • Carries many ethical and legal implications.

53
References
  • Egans fundamentals of respiratory care 9th ed.
  • International Anaesthesiology Clinics Update on
    respiratory critical care , vol 37, no 3, 1999.
  • Anaesthesia newsletter ,Indore city ,June 2009,
    vol 10, no 2
  • David W Chang, Clinical application of mechanical
    ventilation 2nd ed
  • Paul L Marino, The ICU Book, 3rd ed.
  • Weaning from mech. Ventilation, Eur. Respi. J
    2007 29 1033 1056.

54
THANK YOU
55
Ventilator management algorithim
  • Initial intubation
  • FiO2 50
  • PEEP 5
  • RR 12 15
  • VT 8 10 ml/kg

SaO2 lt 90
SaO2 gt 90
  • SaO2 gt 90
  • Adjust RR to maintain PaCO2 40
  • Reduce FiO2 lt 50 as tolerated
  • Reduce PEEP lt 8 as tolerated
  • Assess criteria for SBT daily
  • SaO2 lt 90
  • Increase FiO2 (keep SaO2gt90)
  • Increase PEEP to max 20
  • Identify possible acute lung injury
  • Identify respiratory failure causes

No injury
Pass SBT
Extubate
Airway stable
Acute lung injury
Fail SBT
Airway stable
  • Persistently fail SBT
  • Consider tracheostomy
  • Resume daily SBTs with CPAP or tracheostomy collar
  • Acute lung injury
  • Low TV (lung-protective) settings
  • Reduce TV to 6 ml/kg
  • Increase RR up to 35 to keep pH gt 7.2, PaCO2 lt 50
  • Adjust PEEP to keep FiO2 lt 60

Pass SBT
Intubated gt 2 wks
SaO2 lt 90
SaO2 gt 90
Prolonged ventilator dependence
  • SaO2 lt 90
  • Dx/Tx associated conditions (PTX, hemothorax,
    hydrothorax)
  • Consider adjunct measures (prone positioning,
    HFOV, IRV)
  • SaO2 gt 90
  • Continue lung-protective ventilation until
  • PaO2/FiO2 gt 300
  • Criteria met for SBT
  • Consider PSV wean (gradual reduction of pressure
    support)
  • Consider gradual increases in SBT duration until
    endurance improves

Pass SBT
Write a Comment
User Comments (0)
About PowerShow.com